EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway

Li He, Heng Chen, Bin Ruan, Li He, Ming Luo, Yulun Fu, Rui Zou

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05862-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Li He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The People's Hospital of Xinyu City, Xinyu, Jiangxi, 338099, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proto-Oncogene Proteins c-akt, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ubiquilin-4 (UBQLN4), a member of the ubiquilin family, has received limited attention in cancer research to date. Here, we investigated for the first time the functional role and mechanism of UBQLN4 in non-small cell lung cancer (NSCLC).

Methods

The Cancer Genome Atlas (TCGA) database was employed to validate UBQLN4 as a differentially expressed gene. Expression differences of UBQLN4 in NSCLC cells and tissues were assessed using immunohistochemistry (IHC) experiment and western blotting (WB) experiment. Kaplan-Meier analysis was conducted to examine the association between UBQLN4 expression and NSCLC prognosis. Functional analyses of UBQLN4 were performed through cell counting kit-8 (CCK-8), colony formation, and transwell invasion assays. The impact of UBQLN4 on tumor-associated signaling pathways was assessed using the path scan intracellular signaling array. In vivo tumorigenesis experiments were conducted to further investigate the influence of UBQLN4 on tumor formation.

Results

UBQLN4 exhibited up-regulation in both NSCLC tissues and cells. Additionally, over-expression of UBQLN4 was associated with an unfavorable prognosis in NSCLC patients. Functional loss analyses demonstrated that inhibiting UBQLN4 could suppress the proliferation and invasion of NSCLC cells in both in vitro and in vivo settings. Conversely, functional gain experiments yielded opposite results. Path scan intracellular signaling array results suggested that the role of UBQLN4 is associated with the PI3K/AKT pathway, a correlation substantiated by in vitro and in vivo tumorigenesis experiments.

Conclusion

We validated that UBQLN4 promotes proliferation and invasion of NSCLC cells by activating the PI3K/AKT pathway, thereby facilitating the progression of NSCLC. These findings underscore the potential of targeting UBQLN4 as a therapeutic strategy for NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene Proteins c-aktCell ProliferationPhosphatidylinositol 3-KinasesAutophagy-Related ProteinsNeoplasm InvasivenessSignal TransductionHumansAnimalsMiceFemaleMalePrognosisCell Line, TumorMice, NudeCell MovementGene Expression Regulation, NeoplasticMiddle AgedAdaptor Proteins, Signal TransducingCarrier ProteinsNuclear Proteins

Stichwörter der Autor:innen

InvasionNon–small cell lung cancer (NSCLC)PI3K/AKT pathwayProliferationUbiquilin-4 (UBQLN4)

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAutophagy-Related ProteinsUBQLN4 protein, humanAdaptor Proteins, Signal TransducingCarrier ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Oncology, The People's Hospital of Xinyu City, Xinyu, Jiangxi, 338099, People's Republic of China.
  • Department of Oncology, The First Affiliated Hospital, Jiangxi Medical Collge, Nanchang University, 17 Yongwai Street, Nanchang, Jiangxi, 330006, People's Republic of China.
  • Department of Pathology, Jingdezhen First People's Hospital, Jingdezhen, Jiangxi, 333000, People's Republic of China.
  • Department of Oncology, The First Affiliated Hospital, Jiangxi Medical Collge, Nanchang University, 17 Yongwai Street, Nanchang, Jiangxi, 330006, People's Republic of China. sjyzr12345678@163.com.

Zitieren

APA

He, L., Chen, H., Ruan, B., He, L., Luo, M., Fu, Y., & Zou, R. (2024). UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05862-8

Vancouver

He L, Chen H, Ruan B, He L, Luo M, Fu Y, et al. UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05862-8

BibTeX
@article{He2024,
  author = {He, Li and Chen, Heng and Ruan, Bin and He, Li and Luo, Ming and Fu, Yulun and Zou, Rui},
  title = {UBQLN4 promotes the proliferation and invasion of non-small cell lung cancer cell by regulating PI3K/AKT pathway},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05862-8}
}
Kostenlos starten →